Caprotec Bioanalytics
Latest round
- Series B
Last raised
- May 2011
Total raised
- $6.4M
Investors
- 3
About Caprotec Bioanalytics
Founded in Berlin, Germany, Caprotec Bioanalytics focuses on delivering bioanalytical solutions.000 mn.944 mn.Caprotec Bioanalytics offers a range of innovative solutions designed to address specific challenges faced by sectors such as healthcare, finance, and retail. Their advanced technology systems enhance operational processes and user experiences, focusing on improving efficiency in workflow management, facilitating real-time communication, and optimizing resource allocation.Caprotec Bioanalytics generates revenue through direct-to-consumer sales and B2B partnerships. Clients typically subscribe to their software solutions or license technology through annual or monthly payment plans, catering to both small businesses and larger enterprises. The company intends to launch upcoming innovative offerings targeting specific industry needs, focusing on enhancing their existing technologies.
Who invested in Caprotec Bioanalytics
3 investors across 2 rounds
See all investors in Caprotec Bioanalytics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Caprotec Bioanalytics
Who invested in Caprotec Bioanalytics?
Caprotec Bioanalytics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Caprotec Bioanalytics raised?
Caprotec Bioanalytics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Caprotec Bioanalytics last raise money?
Caprotec Bioanalytics's most recent round on record is a Series B, in May 2011.
What does Caprotec Bioanalytics do?
Founded in Berlin, Germany, Caprotec Bioanalytics focuses on delivering bioanalytical solutions.
Where is Caprotec Bioanalytics headquartered?
Caprotec Bioanalytics is headquartered in Berlin, Germany.
Which VCs invest in companies like Caprotec Bioanalytics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Caprotec Bioanalytics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Caprotec Bioanalytics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.